Holen Sie sich die Stockscreener-App
0.9132
0.47%
-0.0227
Schlusskurs vom Vortag:
$0.8905
Offen:
$0.935
24-Stunden-Volumen:
15,104
Relative Volume:
0.34
Marktkapitalisierung:
$37.04M
Einnahmen:
$52.35M
Nettoeinkommen (Verlust:
$-18.71M
KGV:
-1.6911
EPS:
-0.54
Netto-Cashflow:
$-5.78M
1W Leistung:
-9.56%
1M Leistung:
-31.82%
6M Leistung:
-30.21%
1J Leistung:
-38.88%
1-Tages-Spanne:
$0.8863
$0.935
1-Wochen-Bereich:
$0.8252
$1.02
52-Wochen-Spanne:
$0.7554
$1.99
Apyx Medical Corp Stock (APYX) Company Profile
Firmenname
Apyx Medical Corp
Sektor
Branche
Telefon
(727) 384-2323
Adresse
5115 ULMERTON ROAD, CLEARWATER, FL
Vergleichen Sie APYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APYX
Apyx Medical Corp
|
0.8863 | 37.04M | 52.35M | -18.71M | -5.78M | -0.54 |
|
ABT
Abbott Laboratories
|
129.85 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.19 | 138.41B | 17.55B | 2.03B | 2.37B | 1.37 |
|
SYK
Stryker Corp
|
365.03 | 129.62B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.84 | 107.92B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.27 | 40.53B | 5.54B | 4.18B | 259.90M | 7.00 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-17 | Eingeleitet | BTIG Research | Neutral |
| 2023-07-14 | Eingeleitet | Stephens | Overweight |
| 2022-05-20 | Eingeleitet | Lake Street | Buy |
| 2019-04-02 | Bestätigt | Dougherty & Company | Buy |
Apyx Medical Corp Aktie (APYX) Neueste Nachrichten
Press Release Distribution & PR Platform - ACCESS Newswire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 - Quantisnow
Apyx Medical Sets Q1 Earnings Date: Latest Results Coming for Renuvion Plasma Technology Maker - Stock Titan
Reviewing Haemonetics (NYSE:HAE) and Apyx Medical (NASDAQ:APYX) - Defense World
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener" - Quantisnow
Apyx Medical’s SWOT analysis: helium-based plasma tech stock faces market headwinds - Investing.com
Apyx Medical (NASDAQ:APYX) & Bluejay Diagnostics (NASDAQ:BJDX) Head-To-Head Review - Defense World
Commonwealth Equity Services LLC Has $833,000 Holdings in Apyx Medical Co. (NASDAQ:APYX) - Defense World
Citizens JMP maintains Apyx Medical stock at Market Perform - Investing.com Australia
Reviewing Apyx Medical (NASDAQ:APYX) and PetVivo (NASDAQ:PETV) - Defense World
FDA-Cleared Renuvion Dominates Skin Tightening Market with Prestigious NewBeauty Award - Stock Titan
Liposuction Surgery Devices Market Growth Report and - GlobeNewswire
Liposuction Surgery Devices Market Growth Report and Company Analysis 2025-2033 Featuring SOLTA MEDICAL, InMode, Genesis Biosystems, Hologic, Apyx Medical, Cynosure, YOLO Medical, and Sciton - Yahoo Finance
APYX DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action – APYX - Business Wire
Apyx Medical Corporation (NASDAQ:APYX) Q4 2024 Earnings Call Transcript - Insider Monkey
Apyx Medical Corp (APYX) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
Apyx Medical Reports 2024 Financial Results and Strategic Plans - TipRanks
APYX stock touches 52-week low at $0.96 amid market challenges - Investing.com Australia
Apyx Medical’s Mixed Earnings Call: Opportunities and Challenges - TipRanks
APYX stock touches 52-week low at $0.96 amid market challenges By Investing.com - Investing.com South Africa
Earnings call transcript: Apyx Medical Q4 2024 beats EPS forecast, stock rises By Investing.com - Investing.com South Africa
Apyx Medical reports Q4 EPS (12c), consensus (16c) - TipRanks
Earnings call transcript: Apyx Medical Q4 2024 beats EPS forecast, stock rises - Investing.com
Apyx Medical Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Apyx Medical earnings beat by $0.04, revenue topped estimates - Investing.com
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Earnings Scheduled For March 13, 2025 - Benzinga
Silver Wheaton, DocuSign, Ulta Beauty set to report earnings Thursday - Investing.com
Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch Health, Johnson & Johnson, Apyx Medical, Hologic, Merz Pharma, Galderma, Cynosure - Yahoo Finance
Bioresorbable Polymers Market Grows with Innovations in Medical Devices - openPR
PSTV Rallies, TOVX Gears Up For VIRAGE Trial Data, Will AVTX's LOTUS Bloom? - RTTNews
Apyx Medical (APYX) Expected to Announce Quarterly Earnings on Thursday - Defense World
Apyx Medical Corp. to Host Earnings Call - ACCESS Newswire
Tuesday's Afternoon Update - Florida Trend
Private Advisor Group LLC Has $491,000 Stock Holdings in Apyx Medical Co. (NASDAQ:APYX) - Defense World
The future of U.S. medical devices companies amid tariff impositions - MSN
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025 - GlobeNewswire
Electrosurgical Devices Market Poised for Significant Growth | - openPR
Cold Plasma Market worth $3.66 billion by 2029 - The Globe and Mail
Apyx Medical Co. (NASDAQ:APYX) Stock Holdings Lifted by Kingsview Wealth Management LLC - Defense World
Kingsview Wealth Management LLC Purchases Shares of 7,182 UBS Group AG (NYSE:UBS) - Defense World
Apyx Medical appoints Shawn Roman as COO, details compensation - Investing.com
Head to Head Survey: PROCEPT BioRobotics (NASDAQ:PRCT) versus Apyx Medical (NASDAQ:APYX) - Defense World
Earnings To Watch: Apyx Medical Corp (APYX) Reports Q4 2024 Resu - GuruFocus.com
Earnings To Watch: Apyx Medical Corp (APYX) Reports Q4 2024 Result - Yahoo Finance
Apyx Medical (NASDAQ:APYX) Shares Up 1.4% – Here’s Why - Defense World
Apyx Medical Corporation Issues Preliminary Revenue Results for Q4 and Full Year 2024 - Defense World
Apyx Medical guides Q4 and FY24 revenue above consensus - MSN
Apyx Medical Sees 25% Q4 Growth in Advanced Energy, Plans AYON Body System Launch for 2025 - StockTitan
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results - GlobeNewswire
Apyx Medical Corporation Submits 510(k) Premarket Notification for AYON Body Contouring System - Defense World
Finanzdaten der Apyx Medical Corp-Aktie (APYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):